Google+ Facebook Twitter Twitter

Biomedical scientists to supply medicines?

A UK-wide project is underway to explore the possibility of enabling biomedical scientists to use Patient Group Directions (PGDs) in order to supply or administer medicines.

NHS England is leading the project and will be working closely with the IBMS and other key stakeholders to explore this proposal.

PGDs are documents that enable groups of patients to receive a specific medicine in a particular clinical situation.

They can be written for use by different registered healthcare professionals who are authorised to do so for the use of one-off treatments, diagnostic tests, or acute episodes of care.

A change to legislation is required to extend the use of PGDs to additional professional groups. This includes a public consultation and consideration of responses by the Commission on Human Medicines.

The commission will then make recommendations to ministers in respect of any legislative change. The process is expected to take around two years.

For further information on this proposal, email

Related Articles

Olympus Cellsens

Olympus driving research forward

With expanded imaging capabilities, Olympus has launched version 2.1 of its imaging platform cellSens.

East Automated Zone Measurement Software

Measurement software upgrade

Synbiosis’ eAST software for automatic zone measurement of antimicrobial susceptibility testing (AST) plates has been upgraded to improve antibiotic SIR (Susceptible, Intermediate, Resistant) category determination.

Bacteria Warfare

Bacteria provoke “warfare”

Some bacteria can release toxins that provoke their neighbours into attacking each other, says a new study.


First Keystone human infection

Keystone virus has made the jump from mosquitoes to humans, with a case now confirmed in Florida.